Risk for osteoporotic fractures in patients with atrial fibrillation using different oral anticoagulants

Published on Dec 1, 2021
· DOI :10.1186/S42444-021-00032-0
Daehoon Kim8
Estimated H-index: 8
(Yonsei University),
Kim Dae-Hoon + 9 AuthorsJoung Boyoung
Sources
Abstract
We aimed to investigate the comparative risk of fracture among patients with atrial fibrillation (AF) treated with warfarin or non-vitamin K antagonist oral anticoagulants (NOACs). Using the Korean National Health Insurance Service database, patients with AF who received a prescription for apixaban, dabigatran, rivaroxaban, or warfarin between 2013 and 2016 were included. Risk of major fractures (osteoporotic hip, vertebral, or pelvic fractures) were compared using inverse probability of treatment weighting. There were 70,481 patients identified (41.3% women; mean [SD] age 70.5 [11.3] years); 16,992 apixaban, 22,514 dabigatran, 27,998 rivaroxaban, and 29,390 warfarin users. During a median follow-up of 390 days, 2412 major fractures occurred with weighted incidences per 100 patient-years of 2.56 for apixaban, 2.39 for dabigatran, 2.78 for rivaroxaban, and 3.43 for warfarin. NOAC use was associated with a lower risk for fracture than warfarin use: HR 0.70 (95% confidence interval [CI] 0.57–0.86) for apixaban, HR 0.69 (95% CI 0.60–0.78) for dabigatran, and HR 0.79 (95% CI 0.70–0.90) for rivaroxaban. In head-to-head comparisons between NOACs, there was no significant difference between apixaban and dabigatran. Rivaroxaban was associated with a higher risk for fracture than dabigatran (HR 1.15, 95% CI 1.02–1.31). In patients with AF, NOAC use may result in a lower risk for osteoporotic fracture compared with warfarin use. Fracture risk does not seem to be altered by the choice of NOAC type, except for rivaroxaban. These associations may help inform benefit–risk assessments when choosing between the different anticoagulant types.
📖 Papers frequently viewed together
6 Citations
17 Citations
References33
Newest
#1Gerhard HindricksH-Index: 90
#2Tatjana S. PotparaH-Index: 37
Last. Caroline L WatkinsH-Index: 35
view all 24 authors...
361 CitationsSource
#1Daehoon Kim (Yonsei University)H-Index: 8
#2Pil Sung YangH-Index: 20
Last. Boyoung Joung (Yonsei University)H-Index: 46
view all 12 authors...
Aims Accumulating evidence shows that atrial fibrillation (AF) is associated with an increased risk of dementia. Catheter ablation for AF prolongs the duration of sinus rhythm, thereby improving the quality of life. We investigated the association of catheter ablation for AF with the occurrence of dementia. Methods and results Using the Korean National Health Insurance Service database, among 194 928 adults with AF treated with ablation or medical therapy (antiarrhythmic or rate control drugs) b...
5 CitationsSource
#1Wallis C.Y. Lau (HKU: University of Hong Kong)H-Index: 15
#2Ching-Lung Cheung (HKU: University of Hong Kong)H-Index: 28
Last. Ian C. K. Wong (HKU: University of Hong Kong)H-Index: 69
view all 10 authors...
A meta-analysis of adverse events reported in randomized controlled trials of direct oral anticoagulants (DOACs) found fewer reports of osteoporotic fracture among users of DOACs compared with user...
11 CitationsSource
#1Huei-Kai Huang (TCU: Tzu Chi University)H-Index: 9
#2Peter P. LiuH-Index: 84
Last. Ching-Hui Loh (TCU: Tzu Chi University)H-Index: 4
view all 7 authors...
AIMS: To evaluate the fracture risk among patients with atrial fibrillation (AF) treated with non-vitamin K antagonist oral anticoagulants (NOACs) or warfarin. METHODS AND RESULTS: We conducted a real-world nationwide retrospective cohort study using Taiwan's National Health Insurance Research Database. All adult patients in Taiwan newly diagnosed with AF between 2012 and 2016 who received NOACs or warfarin were enrolled and followed up until 2017. Patients treated with NOACs were sub-grouped ac...
17 CitationsSource
#1Pamela L. Lutsey (UMN: University of Minnesota)H-Index: 66
#2Faye L. Norby (UMN: University of Minnesota)H-Index: 21
Last. Alvaro Alonso (Emory University)H-Index: 94
view all 7 authors...
Importance Warfarin is prescribed to patients with atrial fibrillation (AF) for the prevention of cardioembolic complications. Whether warfarin adversely affects bone health is controversial. The availability of alternate direct oral anticoagulant (DOAC) options now make it possible to evaluate the comparative safety of warfarin in association with fracture risk. Objective To test the hypothesis that, among patients with nonvalvular AF, use of DOACs vs warfarin is associated with lower risk of i...
24 CitationsSource
Abstract Background Elderly patients in long-term treatment with vitamin K antagonists (VKAs) are at high risk of osteoporotic fractures compared with the background population. It has been speculated that the choice of oral anticoagulant (OAC) may affect the risk of osteoporotic fractures. Objectives The risk of osteoporotic fractures was evaluated among patients with atrial fibrillation treated with VKA or direct oral anticoagulants (DOACs). Methods Patients were identified using the Danish na...
21 CitationsSource
#1Dongmin Kim (DU: Dankook University)H-Index: 3
#2Pil Sung YangH-Index: 20
Last. Boyoung Joung (Yonsei University)H-Index: 46
view all 11 authors...
Aims Atrial fibrillation (AF) is generally regarded as a risk factor for dementia, though longitudinal studies assessing the association between AF and dementia have shown inconsistent results. This study aimed to determine the effect of AF on the risk of developing dementia using a longitudinal, community-based, and stroke-free elderly cohort. Methods and results The association of incident AF with the development of incident dementia was assessed from 2005 to 2012 in 262 611 dementia- and stro...
58 CitationsSource
Glenn N. Levine, MD, FACC, FAHA, Chair Patrick T. O’Gara, MD, MACC, FAHA, Chair-Elect Jonathan L. Halperin, MD, FACC, FAHA, Immediate Past Chair [#][1] Sana M. Al-Khatib, MD, MHS, FACC, FAHA Joshua A. Beckman, MD, MS, FAHA Kim K. Birtcher, PharmD, MS, AACC Biykem Bozkurt, MD, PhD, FACC,
771 CitationsSource
#1Tae Hoon Kim (Yonsei University)H-Index: 38
#2Pil Sung YangH-Index: 20
Last. Gregory Y.H. Lip (University of Birmingham)H-Index: 195
view all 13 authors...
AIMS: There are a paucity of data on the association of duration of hypertension and blood pressure (BP) level with risk of ischaemic stroke in patients with atrial fibrillation (AF). Our objective was to investigate the association between duration of hypertension and secondly, BP levels with risk of ischaemic stroke among patients with AF. METHODS AND RESULTS: A total of 246 459 oral anticoagulant-naive non-valvular AF patients were enrolled from Korea National Health Insurance Service (NHIS) ...
33 CitationsSource
#1Daehoon Kim (University Health System)H-Index: 8
#2Pil Sung YangH-Index: 20
Last. Gregory Y.H. LipH-Index: 195
view all 11 authors...
Objective Temporal changes in the healthcare burden of atrial fibrillation (AF) are less well known in rapidly ageing Asian countries. We examined trends in hospitalisations, costs, treatment patterns and outcomes related to AF in Korea. Methods Using the National Health Insurance Service (NHIS) database involving the entire adult Korean population (n=41 701 269 in 2015), we analysed a nationwide AF cohort representing 931 138 patients with AF. We studied all hospitalisations due to AF from 2006...
47 CitationsSource
Cited By0
Newest